1. Medtech Insight
  2. >>Geography
  3. >>Europe

Stentys' IPO: European Public Markets Opening For Device Companies?

The emerging device companies that have been hardest hit by the economic woes of the past couple of years have been those looking for later-stage financing. These companies face venture investors who are either unwilling or unable to invest in late-stage deals, while also confronting an IPO market that largely remains closed to them, particularly in the US. In Europe, however, that may be changing, most notably in France, where Stentys SAS, which is developing stents to treat acute myocardial infarctions, recently became the second device company to successfully go public this year.

The emerging device companies that have been hardest hit by the economic woes of the past couple of years have been those looking for later-stage financing. These companies face venture investors who are either unwilling or unable to invest in late-stage deals, while also confronting an IPO market that largely remains closed to them, particularly in the US. In Europe, however, that may be changing, most notably in France, where Stentys SAS, which is developing stents to treat acute myocardial infarctions (AMIs), recently became the second device company to successfully go public this year. [See Deal] (The other was Carmat SAS, an artificial heart company founded by noted cardiac surgeon Alain Carpentier, MD.) [See Deal]

Gonzague Issenmann, Stentys' CEO, acknowledges that the company's timing has been fortunate, having raised its last round of financing in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

A Year After Exiting The Ventilator Market, Medtronic Recalls Thousands Of Newport Devices

 
• By Brian Bossetta

After two serious injuries and one death linked to some of its ventilators, Medtronic has recalled the devices and asked customers to stop using them and find alternative means. The action comes more than a year after the company left the market.

‘UK Must Put Adoption On A Par With Innovation’

 
• By Ashley Yeo

Market access concerns dominated at the annual BioWales In London event, where AstraZeneca set out industry’s priorities and the UK Office for Life Sciences struck an optimistic tone about how the UK will lastingly improve uptake of innovation.

Sofinnova And NVIDIA Partner To ‘Supercharge’ Computation For European Startups

 
• By Natasha Barrow

European venture capital firm Sofinnova Partners’ portfolio companies BioCorteX, Bioptimus, Cure51 and Latent Labs will benefit from the investor’s new partnership with tech giant NVIDIA.

Medtechs Wait For Dividend As UK Spending Review Prioritizes Healthcare And NHS

 
• By Ashley Yeo

Increased support for NHS services and delivery infrastructure announced in the 11 June government spending review by chancellor of the exchequer Rachel Reeves could boost inward investment and offer new market opportunities for medtechs.

More from Geography

MDUFA VI Launches With Public Meeting, Call For Comments

 
• By Elizabeth Orr

Preparations for the reauthorization of the Medical Device User Fee Amendments for 2028-2032 are underway, with the US FDA announcing a public meeting for 4 August. After negotiations with industry and other stakeholders, a draft agreement is due to Congress by 15 January 2025.

Permanent FDA Top Lawyer Expected After HHS Counsel Confirmation

 
• By Sue Sutter

Robert Foster, HHS deputy general counsel and chief counsel for food, research and drugs, is temporarily heading the Office of Chief Counsel, but a permanent appointee is expected after Michael Stuart's confirmation as HHS general counsel.

FDA Drops Package Labeling Guidance For Hernia Mesh Manufacturers

 
• By Brian Bossetta

The US FDA recently published a draft guidance document for manufacturers of mesh products that are used during several types of hernia repair procedures.